Mining the potential therapeutic targets for COVID-19 infection in patients with severe burn injuries via bioinformatics analysis

被引:0
|
作者
Cai, Xueyao [1 ]
Deng, Jing [1 ]
Shi, Wenjun [2 ]
Cai, Yuchen [2 ,3 ]
Ma, Zhengzheng [1 ,4 ]
机构
[1] Dongguan Tungwah Hosp, Dept Burn & Plast Surg, Dongguan, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, 639 Zhi Zao-Ju Rd, Shanghai 200011, Peoples R China
[4] Dongguan Tungwah Hosp, Dept Burn & Plast Surg, 1 Dongcheng East Rd, Dongguan 523000, Peoples R China
关键词
COVID-19; differentially expressed genes; hub genes; severe burn; therapy; CELLS;
D O I
10.1111/iwj.14151
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The Coronavirus Disease-19 (COVID-19) pandemic is posing a serious challenge to human health. Burn victims are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leading to delayed recovery and even profound debilitation. Nevertheless, the molecular mechanisms underlying COVID-19 and severe burn are yet to be elucidated. In our work, the differentially expressed genes (DEGs) were identified from GSE157852 and GSE19743, and the common DEGs between COVID-19 and severe burn were extracted. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interactions (PPI), gene coexpression network, and multifactor regulatory network analysis of hub genes were carried out. A total of 44 common DEGs were found between COVID-19 and severe burn. Functional analyses indicated that the pathways of immune regulation and cytokine response participated collectively in the development of severe burn and progression of COVID-19. Ten significant hub genes were identified, including MERTK, SIRPA, TLR3, ITGB1, DPP4, PTPRC, LY75, IFIT1, IL4R, and CD2. In addition, the gene coexpression network and regulatory network were constructed containing 42 microRNAs (miRNAs) and 2 transcription factors (TFs). Our study showed the shared pathogenic link between COVID-19 and severe burn. The identified common genes and pivotal pathways pave a new road for future mechanistic researches in severe burn injuries complicated with COVID-19.
引用
收藏
页码:2742 / 2752
页数:11
相关论文
共 50 条
  • [21] Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis
    Lai, Yanni
    Han, Tiantian
    Lao, Zizhao
    Li, Geng
    Xiao, Jianyong
    Liu, Xiaohong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] Clofazimine: A potential therapeutic option for severe COVID-19
    Ateya, Areej Mohamed
    MEDICAL HYPOTHESES, 2021, 150
  • [23] Recent advances of therapeutic targets and potential drugs of COVID-19
    Zhang, W.
    Zhang, P.
    Wang, G.
    Cheng, W.
    Chen, J.
    Zhang, X.
    PHARMAZIE, 2020, 75 (05): : 161 - 163
  • [24] The Therapeutic Potential of Spirulina to Combat COVID-19 Infection
    El-Sheekh, Mostafa
    Ahomohra, Abd El-Fatah
    EGYPTIAN JOURNAL OF BOTANY, 2020, 60 (03): : 605 - 609
  • [25] Potential neurological effects of severe COVID-19 infection
    Nuzzo, Domenico
    Picone, Pasquale
    NEUROSCIENCE RESEARCH, 2020, 158 : 1 - 5
  • [26] Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
    Matias-Guiu, Jorge
    Montero-Escribano, Paloma
    Pytel, Vanesa
    Porta-Etessam, Jesus
    Matias-Guiu, Jordi A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 44
  • [27] Therapeutic plasma exchange in adults with severe COVID-19 infection
    Khamis, Faryal
    Al-Zakwani, Ibrahim
    Al Hashmi, Sabria
    Al Dowaiki, Samata
    Al Bahrani, Maher
    Pandak, Nenad
    Al Khalili, Huda
    Memish, Ziad
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 214 - 218
  • [28] Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
    Misra, Durga Prasanna
    Agarwal, Vikas
    Gasparyan, Armen Yuri
    Zimba, Olena
    CLINICAL RHEUMATOLOGY, 2020, 39 (07) : 2055 - 2062
  • [29] Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
    Durga Prasanna Misra
    Vikas Agarwal
    Armen Yuri Gasparyan
    Olena Zimba
    Clinical Rheumatology, 2020, 39 : 2055 - 2062
  • [30] Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection?
    Singh, Harmanjit
    Chauhan, Prerna
    Singh, Jasbir
    Saurabh, Saurabh
    Gautam, C. S.
    Kakkar, Ashish Kumar
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (03) : 315 - 322